Skip to main content
Clinical Trials/NCT04866199
NCT04866199WithdrawnNot Applicable

Peri-Operative Metabolic & Mitochondrial Phenotype Study: Prediction From Three Preoperative Assessments

Duke University0 sitesStarted: October 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Primary Endpoint
Change in mitochondrial oxygen consumption as measured by blood analysis

Study Overview

Brief Summary

Patients scheduled for bladder or bowel resection will receive assessments at three time points:

  1. Preoperatively up to 30 days prior to scheduled surgery
  2. Postoperatively in hospital up to 5 days
  3. Postoperatively up to 30 days following scheduled surgery

At all time points the subjects will have blood samples drawn for mitochonrial function analysis and a muscle ultrasound (MuscleSound) performed. In addition, a cardiopulmonary exercise test (CPET or 'VO2 max') will be performed at the 30 day pre/post evaluation time points.

Detailed Description

Cardiorespiratory fitness (CRF) is a measure of the efficiency to use oxygen. One method used to measure CRF is the cardiopulmonary exercise test (CPET), otherwise known as 'VO2 max'. Previous studies have shown that individuals assessed with CPET-derived parameters, such as VO2 max or anaerobic threshold (AT), below specific thresholds are at greater risk of post-operative complications, which can occur in up to 40% of surgical patients.

This study wants to determine if other methods of fitness or well-being, such as mitochondrial oxygen consumption and muscle ultrasound to determine muscle characteristics, can be combined with CPET assessment to improve the ability to identify surgical patients who develop postoperative complications, as measured by the validated tool, POMS.

The objective of the study is to create a method to identify the metabolic and mitochondrial phenotype of the perioperative patient, termed the POM-MP.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults aged >18 undergoing bladder or bowel resection
  • Able to speak English
  • Ambulatory (assistive devices OK)
  • Able to consent
  • Willing to perform Cardiopulmonary Exercise Testing

Exclusion Criteria

  • Unable to perform CPET
  • Patients with diagnosed Dementia
  • Unable to ambulate independently

Outcomes

Primary Outcomes

Change in mitochondrial oxygen consumption as measured by blood analysis

Time Frame: Baseline (preop), postop Days 0, 1, 3 & 5, and Post-op (up to 30 days)

The change between baseline and maximal oxygen consumption when maximum induced by additon of chemicals in vivo

Number of participants with post-operative complications as measured by Postoperative Morbidity Survey (POMS)

Time Frame: Up to 30 days post-op

Nine-domain tool used to assess the presence (or absence) of clinically significant changes using specified criteria. Confirmation of yes in any domain represents post-operative morbidity.

Change in the highest oxygen consumption (VO2 peak) as measured by wearable face mask

Time Frame: Baseline (preop) and Post-op (up to 30 days)

Measured in milliliters of oxygen per min

Change in MuscleSound %iMAT as measured by portable ultrasound

Time Frame: Baseline (preop), postop Days 0, 1, 3 & 5, and Post-op (up to 30 days)

The parameter is derived using a proprietary algorithm applied to the ultrasound image to estimate the amount of intramuscular adipose tissue, presented as percentage

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials